ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc (1MDGL)

0,00
0,00
(0,00%)
Geschlossen 28 Juni 5:30PM

Madrigal Pharmaceuticals Inc (1MDGL) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
-
( - )
Gebot
-
Fragen
-
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
-
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
314.550 €
Ausgegebene Aktien
23.055.659
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-37,35
Gewinn pro Aktie (EPS)
-13,65
Erlöse (LTM)
1,13B
Nettogewinn (LTM)
-309,44M

Über Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was found... Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania. Mehr anzeigen

Sektor
-
Branche
-
Hauptsitz
West Conshohocken, United States
Gegründet
2026
Madrigal Pharmaceuticals Inc is listed in the sector of the Italienische Börse with ticker 1MDGL. The last closing price for Madrigal Pharmaceuticals was -. Over the last year, Madrigal Pharmaceuticals shares have traded in a share price range of 0,00 € to 0,00 €.

Madrigal Pharmaceuticals currently has 23.055.659 shares in issue. Madrigal Pharmaceuticals has a price to earnings ratio (PE ratio) of -37.35.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

1MDGL - Frequently Asked Questions (FAQ)

What is the current Madrigal Pharmaceuticals Inc share price?
The current share price of Madrigal Pharmaceuticals Inc is 0,00 €
How many Madrigal Pharmaceuticals Inc shares are in issue?
Madrigal Pharmaceuticals Inc has 23.055.659 shares in issue
What is the 1 year trading range for Madrigal Pharmaceuticals Inc share price?
Madrigal Pharmaceuticals Inc has traded in the range of 0,00 € to 0,00 € during the past year
What is the PE ratio of Madrigal Pharmaceuticals Inc?
The price to earnings ratio of Madrigal Pharmaceuticals Inc is -37,35
What is the cash to sales ratio of Madrigal Pharmaceuticals Inc?
The cash to sales ratio of Madrigal Pharmaceuticals Inc is 10,38
What is the registered address of Madrigal Pharmaceuticals Inc?
The registered address for Madrigal Pharmaceuticals Inc is Four Tower Bridge, West Conshohocken, Pennsylvania, 19428
What is the Madrigal Pharmaceuticals Inc website address?
The website address for Madrigal Pharmaceuticals Inc is www.madrigalpharma.com

1MDGL Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen